ArticleJournal of translational medicine2022

Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).

Yu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.